CIK 0001280776
- Non-accelerated filer
- Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562358443
- Phone
- +1 332-255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +120,000 | 120,000 | ||
| 2025-07-16 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Appreciation Right | +280,000 | 280,000 | ||
| 2025-07-16 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Appreciation Right | +560,000 | 560,000 | ||
| 2025-07-16 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Appreciation Right | +560,000 | 560,000 | ||
| 2025-07-16 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Appreciation Right | +280,000 | 280,000 | ||
| 2025-07-16 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Appreciation Right | +280,000 | 280,000 | ||
| 2025-06-05 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +503,500 | 503,500 | ||
| 2025-06-05 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +503,000 | 503,000 | ||
| 2025-06-03 | Whaley Glenn Chief Financial Officer | Purchase | +45,000 | $0.71 | $32K | 95,510 |
| 2025-05-30 | Whaley Glenn Chief Financial Officer | Grant or award | +25,000 | $0.56 | $14K | 50,510 |
| 2024-12-04 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +265,000 | 265,000 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −15,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −15,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −30,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −40,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −70,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −40,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +220,000 | 220,000 | ||
| 2024-01-17 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +295,400 | 295,400 |
Page 1 of 2 · 35 trades